The MarketWatch News Department was not involved in the creation of this content. MIRAMAR, Fla., Feb. 12, 2026 /PRNewswire/ -- DifGen Pharmaceuticals, a leading US based generic pharmaceutical company ...

CGT designations are granted to medicines with limited generic competition, and first‑approved applicants are eligible for six months of exclusivity—an incentive aimed at encouraging development of ...

Jointly developed HIV-1 therapy leverages STEERLife's proprietary solvent-free FragMelt™ continuous processing platform to address complex formulation challenges NEW YORK and BENGALURU, India, Jan. 13 ...

Pentasa is an aminosalicylate indicated for the induction of remission and for the treatment of mildly to moderately active ulcerative colitis in adult patients.

The MarketWatch News Department was not involved in the creation of this content. Therapeutically Equivalent to PENTASA(R) MIRAMAR, Fla., March 11, 2026 /PRNewswire/ -- DifGen Pharmaceuticals LLC, a U ...

Chennai: Caplin Steriles Limited, a wholly owned subsidiary of Caplin Point Laboratories Limited, has received final approval ...

To fund this transition and strengthen balance sheet, the company completed a Rs1,762.50 crore capital-raise in February 2026.

Biocon Limited's wholly owned subsidiary Biocon Pharma Limited has received approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application ...

MUMBAI, India and WARREN, N.J., Feb. 27, 2026 /PRNewswire/ -- Cipla USA Inc. the wholly owned subsidiary of Cipla Limited(BSE: 500087; NSE: CIPLA; and hereafter referred to as "Cipla") today announced ...

The drug has been granted a Competitive Generic Therapy designation by the US FDA. Glenmark is recognized as the first approved applicant under the relevant provisions of the Federal Food, Drug, and ...